SIMULECT Trademark

Trademark Overview

On Wednesday, September 24, 2008, a trademark application was filed for SIMULECT with the United States Patent and Trademark Office. The USPTO has given the SIMULECT trademark a serial number of 79059709. The federal status of this trademark filing is SECTION 71 ACCEPTED as of Thursday, April 4, 2019. This trademark is owned by Novartis AG. The SIMULECT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of disorders of the [ nervous system, ] the immune system [, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; ] for use in [ dermatology, oncology, hematology and ] in tissue and organ transplantation [, in ophthalmology, and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases; for the treatment of bacteria-based diseases; for the treatment of diabetes, anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations ]
simulect

General Information

Serial Number79059709
Word MarkSIMULECT
Filing DateWednesday, September 24, 2008
Status706 - SECTION 71 ACCEPTED
Status DateThursday, April 4, 2019
Registration Number3639864
Registration DateTuesday, June 16, 2009
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 31, 2009

Trademark Statements

Goods and ServicesPharmaceutical preparations for the prevention and treatment of disorders of the [ nervous system, ] the immune system [, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; ] for use in [ dermatology, oncology, hematology and ] in tissue and organ transplantation [, in ophthalmology, and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases; for the treatment of bacteria-based diseases; for the treatment of diabetes, anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations ]

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, November 3, 2008
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBasel 4002
CH
Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCH
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCH

Trademark Events

Event DateEvent Description
Friday, February 7, 2020PARTIAL INVALIDATION PROCESSED BY THE IB
Monday, December 23, 2019PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Monday, December 23, 2019INVALIDATION PROCESSED
Wednesday, December 4, 2019PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Thursday, April 4, 2019NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Thursday, April 4, 2019REGISTERED-SEC.71 ACCEPTED
Tuesday, March 19, 2019TEAS SECTION 71 RECEIVED
Thursday, October 11, 2018INTERNATIONAL REGISTRATION RENEWED
Saturday, June 16, 2018COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Thursday, June 25, 2015NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Thursday, June 25, 2015REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Thursday, June 25, 2015CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, June 1, 2015TEAS SECTION 71 & 15 RECEIVED
Saturday, April 13, 2013NEW REPRESENTATIVE AT IB RECEIVED
Saturday, February 23, 2013CHANGE OF NAME/ADDRESS REC'D FROM IB
Friday, December 11, 2009FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, September 25, 2009FINAL DISPOSITION NOTICE SENT TO IB
Friday, September 25, 2009FINAL DISPOSITION PROCESSED
Thursday, September 17, 2009FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, June 26, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, June 26, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 16, 2009REGISTERED-PRINCIPAL REGISTER
Tuesday, March 31, 2009PUBLISHED FOR OPPOSITION
Wednesday, March 11, 2009NOTICE OF PUBLICATION
Friday, February 20, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, February 20, 2009ASSIGNED TO LIE
Thursday, February 12, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, February 12, 2009EXAMINER'S AMENDMENT ENTERED
Thursday, February 12, 2009NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, February 12, 2009EXAMINERS AMENDMENT E-MAILED
Thursday, February 12, 2009EXAMINERS AMENDMENT -WRITTEN
Thursday, February 5, 2009REFUSAL PROCESSED BY IB
Tuesday, February 3, 2009ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 3, 2009TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, December 16, 2008NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, December 16, 2008REFUSAL PROCESSED BY MPU
Saturday, December 13, 2008NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, December 12, 2008NON-FINAL ACTION WRITTEN
Wednesday, December 3, 2008ASSIGNED TO EXAMINER
Friday, November 7, 2008APPLICATION FILING RECEIPT MAILED
Monday, November 3, 2008NEW APPLICATION ENTERED IN TRAM
Friday, October 31, 2008LIMITATION OF GOODS/SERVICES FROM IB ENTERED
Thursday, October 30, 2008SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

simulect system treatment preparations disorders pharmaceutical diseases prevention ocular transplantation bacteria